KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Working Capital Changes (2016 - 2025)

AbbVie (ABBV) has disclosed Other Working Capital Changes for 14 consecutive years, with $658.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 558.0% to $658.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $827.0 million, a 329.09% increase, with the full-year FY2025 number at $827.0 million, up 329.09% from a year prior.
  • Other Working Capital Changes was $658.0 million for Q4 2025 at AbbVie, up from -$88.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $658.0 million in Q4 2025 to a low of -$452.0 million in Q2 2023.
  • A 5-year average of $55.8 million and a median of $24.5 million in 2022 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 3100.0% in 2021, then tumbled 1384.0% in 2025.
  • AbbVie's Other Working Capital Changes stood at -$265.0 million in 2021, then soared by 176.98% to $204.0 million in 2022, then surged by 185.29% to $582.0 million in 2023, then plummeted by 82.82% to $100.0 million in 2024, then soared by 558.0% to $658.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Working Capital Changes are $658.0 million (Q4 2025), -$88.0 million (Q3 2025), and -$371.0 million (Q2 2025).